The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone

Experimental and Clinical Endocrinology and Diabetes

Volumn 111, Issue 2, 2003, Pages 66-72

  Pepene, Carmen Emanuela ^a,b   Seck, T ^a   Pfeilschifter, J ^a   Gozariu, L ^b   Ziegler, R ^a   Kasperk, C H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Osteoblasts; Somatotropin; Somatotropin receptors; Thyroid hormone

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; LIOTHYRONINE; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN 1; THYROID HORMONE; UNCLASSIFIED DRUG;

ARTICLE; BONE MASS; BONE METABOLISM; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; TRABECULAR BONE;

ADULT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; DNA REPLICATION; DNA, COMPLEMENTARY; HUMAN GROWTH HORMONE; HUMANS; OSTEOBLASTS; POLYMERASE CHAIN REACTION; PROCOLLAGEN; RNA, MESSENGER; THYMIDINE; TRIIODOTHYRONINE;

EID: 0037396267     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39231     Document Type: Article

References (52)

1. Abu EG, Bord S, Horner A, Chatterjee KK, Compston JE. The expression of thyroid hormone receptors in human bone. Bone 1997; 21: 137-142
2. Allain TJ, Yen PM, Flanagan AM, McGregor AM. The isoform-specific expression of the tri-iodothyronine receptor in osteoblasts and osteoclasts. Eur J Clin Invest 1996; 26: 418-425
3. Amit T, Hertz P, Ish-Shalom S, Lotan R, Luboshitzki R, Youdim MB, Hochberg Z. Effects of hypo or hyper-thyroidism on growth hormone-binding protein. Clin Endocrinol 1991; 35; 159-162
4. Bengtsson BA, Eden S, Lonn L. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-317
5. Brameld JM, Weller PA, Saunders JC, Buttery PC, Gilmour RS. Hormonal control of insulin-like growth factor-I and growth hormone receptor RNA expression by porcine hepatocytes in culture. J Endocrinol 1995; 146: 239-245
6. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994; 134: 169-176
7. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 1990; 5: 609-618
8. Calvo M, Eyre D, Gundberg C. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996; 17: 333-368
9. 3 and activity on human osteoblast-like cells in short-term cultures. Bone 1990; 11: 81-86
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162: 156-159
11. Chomczynski P, Soszynski PA, Frohman LA. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J Clin Endocrinol Metab 1993; 77: 281-285
12. Cooper DS, Kaplan MM, Ridgway EC, Maloof F, Daniels GH. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 1979; 90: 164-168
13. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992; 126: 387-393
14. Eriksen EF, Kassem M, Brixen K. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res 1993; 40: 95-98
15. Ernst M, Froesch ER. Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture FEBS Lett 1987; 220: 163-166
16. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 1994; 78: 955-959
17. Hansen TB, Brixen K, Vahl N, Jorgensen JOO, Christiansen JS, Mosekilde L, Hagen, C. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis and bone metabolism in adults with acquired GH deficiency: a double blind, randomised, placebo-controlled study. J Clin Endocrinol Metab 1996; 81: 3352-3359
18. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF-binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 1995; 10: 854-858
19. Kasperk CH, Fitzsimmons R, Strong D, Mohan S, Jennings J, Werdegal J, Baylink D. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 1990; 71: 1322-1329
20. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993 a; 52: 222-226
21. Kassem M, Mosekilde L, Eriksen EF. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem Mol Biol Int 1993 b; 30: 779-788
22. Korytko AI, Cuttler L. Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression. J Endocrinol 1997; 152: 13-17
23. Krieger NS, Stappenbeck TS, Stern PH. Characterization of specific thyroid hormone receptors in bone. J Bone Miner Res 1988; 3: 473-478
24. Kung Sutherland M, Rao LG, Sodek J, Wylie J, Ly H, Haussler MR, Murray TM. Regulation of thyroid hormone receptor gene expression in osteoblastic SaOs-2 cells [Abstract No. 62] J Bone Miner Res 1990; 5 (Suppl): 89
25. Lalau JD, Sebert JL, Marie A, Fournier A, Quichaud J. Effect of thyrotoxicosis and its treatment on mineral and bone metabolism. J Endocrinol Invest 1986; 491-496
26. Lakatos P, Caplice MD, Khanna V, Stern PH. Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue. J Bone Miner Res 1993; 8: 1475-1481
27. LeBron BA, Pekary EA, Mirell C, Hahn T, Hershman JM. Thyroid hormone 5′-deiodinase activity, nuclear binding and effects on mitogenesis in UMR-106 osteoblastic osteosarcoma cells. J Bone Miner Res 1989; 4: 173-178
28. Lee M, Kim SY, Lee CL, Cho BY, Lee HK, Koh CS, Min HK. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 1990; 70: 766-770
29. Lewinson D, Harel Z, Shenzer P, Silbermann M, Hochberg Z. Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone. Endocrinology 1989; 124: 937-945
30. Lewinson D, Bialik GM, Hochberg Z. Differential effects of hypothyroidism on the cartilage and the osteogenic process in the mandibular condyle: recovery by growth hormone and thyroxine. Endocrinology 1994; 135: 1504-1510
31. Miki N, Ono M, Murata Y, Ohsaki E, Tamitsu K, Ri T, Demura H, Yamada M. Thyroid hormone regulation of gene expression of the pituitary growth-hormone releasing factor receptor. Biochem Biophys Res Commun 1995; 217: 1087-1093
32. Milne M, Kang M, Quail JM, Baran DT. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures. Endocrinology 1998; 139: 2527-2534
33. Mohan S, Strong D, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. Acta Endocrinol 1992; 127: 555-564
34. Mosekilde L, Christensen MS. Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function. Acta Endocrinol 1977; 84: 566-575
35. Nilsson A, Swolin D, Enerback S, Ohlsson C. Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab 1995; 80: 3483-3488
36. Rizzoli R, Poser J, Burgi U. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 1986; 35: 71-74
37. Rosen T, Johansson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson BA. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. J Clin Endocrinol Metab 1994; 1: 55-66
38. Saggesse G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency J Pediatr 1993; 122: 37-45
39. Sato K, Han DC, Fuji Y, Tsushima T, Shizume K. Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodo-L-thyronine nuclear receptors. Endocrinology 1987; 120: 1873-1881
40. Scheven BA, Hamilton J, Fakkeldij TM, Duursma SA. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regulation 1991; 1: 160-167
41. 3) stimulates insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol 1992; 126: 467-473
42. Shen XY, Rodriguez-Arnao J, Ross RJ. Regulation of hepatic RNA levels for the growth hormone receptor in rats with altered thyroid status. Growth Regulation 1995; 5: 199-202
43. Slootweg M, Ohlsson C, Salles JP, de Vries CP, Netelenbos J. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 1995; 136: 4210-4217
44. Slootweg MC, Salles JP, Ohlsson C, de Vries CP, Engelbregt MJ, NetelenbosJC. Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acids and cell differentiation. J Endocrinol 1996; 150: 465-472
45. Slootweg MC, Swolin D, Netelenbos JC, Isaksson OG, Ohlsson C. Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells. J Endocrinol 1997; 155: 159-164
46. Slootweg MC, Vangenesen ST, Otte AP, Duursma SA, Kruijer W. Activation of mouse osteoblast growth hormone receptor c-fos oncogene expression independent of phosphoinositide breakdown and cyclic AMP. J Mol Endocrinol 1990; 120: 1806-1812
47. Swollin-Eide D, Nilsson A, Ohlsson C. Cortisol increases growth hormone-receptor expression in human osteoblast-like cells. J Endocrinol 1998; 136: 99-105
48. Tam SP, Lam KS, Srivastava G. Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism. Endocrinology. 1996; 137: 418-424
49. Varga F, Rumpler M, Klaushofer K. Thyroid hormones increase insulinlike growth factor mRNA levels in the clonal osteoblastic cell line MC3T3-E1. FEBS Lett 1994; 345: 67-70
50. Varga F, Rumpler M, Luegmayr E, Fratzl-Zelman N, Glantschnig H, Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun and induction of osteocalcin expression Calcif Tissue Int 1997; 61: 404-411
51. Vanderveen EA, Netelenbos JC. Growth hormone (replacement) therapy in adults-bone and calcium metabolism. Horm Res 1990; 33: 65-68
52. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993; 39: 409-415